Refine your search

P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries

Abstract Aims Non-ST-elevation acute coronary syndrome (NSTE-ACS) is present in about 6070% of patients admitted with acute coronary syndromes in clinical practice. The current guidelines of the ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Uwe Zeymer, Petr Widimsky, Nicolas Danchin, Maddalena Lettino, Alfredo Bardaji, Jose A. Barrabes, Angel Cequier, Marc J. ...

Date : 03/03/2016 Item size : 360655 bytes

P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries

Abstract Aims Non-ST-elevation acute coronary syndrome (NSTE-ACS) is present in about 6070% of patients admitted with acute coronary syndromes in clinical practice. The current guidelines of the ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Articles, Uwe Zeymer, Petr Widimsky, Nicolas Danchin, Maddalena Lettino, Alfredo Bardaji, Jose A. Barrabes, Angel Cequier, Marc J. ...

Date : 01/10/2016 Item size : 357401 bytes

Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries

Current European Society of Cardiology (ESC) guidelines highlight the benefit of dual antiplatelet therapy (DAPT) consisting of acetylic salicylic acid plus one of the P2Y12 receptor inhibitors, ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Nicolas Danchin, Maddalena Lettino, Uwe Zeymer, Petr Widimsky, Alfredo Bardaji, Jose A. Barrabes, Angel Cequier, Marc J. ...

Date : 01/07/2016